Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of chitosan drug loading system and its preparation method and application

A drug-carrying system, chitosan technology, applied in the field of preparation of tumor treatment materials, can solve the problems of chemotherapy failure, drug tolerance, etc., and achieve a strong inhibitory effect

Active Publication Date: 2022-03-22
SOUTH CHINA INST OF COLLABORATIVE INNOVATION
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Pancreatic cancer is a common malignant gastrointestinal tumor. The current standard drug for clinical treatment of pancreatic cancer is gemcitabine, although gemcitabine and gemcitabine-based combination therapy have played a certain role in prolonging the survival of patients and improving their survival. , but most patients develop drug resistance after receiving treatment for several weeks, leading to chemotherapy failure

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of chitosan drug loading system and its preparation method and application
  • A kind of chitosan drug loading system and its preparation method and application
  • A kind of chitosan drug loading system and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Embodiment 1 Modified Chitosan Loading CPI-613 and Gemcitabine

[0040] 1. PLLA loaded with CPI-613

[0041] 1) Dissolve 100mg of PLLA in 1mL of dichloromethane, place in a shaker, and shake at 150rpm for 30min; then add 10mg of CPI-613 to form a primary emulsifier, and shake for 2min. Then add 3 mL of 3% polyvinyl alcohol aqueous solution to form a secondary emulsifier, and shake for 2 minutes. Continue to add 20mL of 0.3% PVA aqueous solution, place it in an ultrasonic machine, and after ultrasonication at 450W for 10min, dilute the solution to 50mL, centrifuge to remove the supernatant, and collect microspheres.

[0042] 2. PLLA-CPI613 was further loaded into modified chitosan

[0043]1) Weigh 100mg modified chitosan

[0044] 2) Add 10 mL of 0.5% acetic acid, place in a shaker, 150 rpm, and shake overnight to obtain a modified chitosan acetic acid solution.

[0045] 3) Take 10mg of PLLA particles containing CPI-613, add it to 10mL modified chitosan acetic acid so...

Embodiment 2

[0047] Example 2 Effect of CPI-613 on the proliferation of pancreatic cancer cells

[0048] 1. Experimental materials

[0049] (1) Drug: CPI-613 in this example is the experimental drug.

[0050] The chemical structural formula of CPI-613 is as follows:

[0051]

[0052] (2) Pancreatic cancer cells: human pancreatic cancer cells BxPC-3 and PANC-1.

[0053] (3) CellTiter-Glo, a commercially available cell proliferation detection kit.

[0054] 2. Experimental grouping

[0055] (1) Control group: blank control, that is, the cancer cells were not treated with any drugs.

[0056] (2) Experimental group: Pancreatic cancer cells were treated with CPI-613 at different concentrations and at different times.

[0057] 3. CellTiter-Glo kit detects the effect of CPI-613 on the proliferation of pancreatic cancer cells

[0058] (1) Spread 8,000 pancreatic cancer cells in a 96-well plate, add 0 μM, 50 μM, 70 μM, and 90 μM CPI-613 to treat the cells for 24 h, 48 h, and 72 h, and then ...

Embodiment 3

[0073] Example 3 Effect of CPI-613 combined with gemcitabine on the proliferation of pancreatic cancer cells

[0074] 1. Experimental materials

[0075] (1) medicine: with embodiment 1

[0076] (2) cancer cell: with embodiment 1

[0077] (3) CellTiter-Glo, a commercially available cell proliferation detection kit.

[0078] 2. Experimental grouping

[0079] (1) Control group: blank control, that is, pancreatic cancer without any drug treatment.

[0080] (2) Single medication group 1: use gemcitabine to treat pancreatic cancer cells.

[0081] (3) Single medication group 2: Pancreatic cancer cells were treated with CPI-613.

[0082] (4) Combined drug group: use CPI-613 and gemcitabine to treat pancreatic cancer cells.

[0083] 3. The effect of CPI-613 combined with gemcitabine on the proliferation of BxPC-3 and PANC-1 cells was detected by CellTiter-Glo method.

[0084] (1) Pancreatic cancer cells were spread in a 96-well plate, and after they adhered to the wall, the cont...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of preparation of tumor treatment materials, and specifically discloses a chitosan drug-carrying system, a preparation method and an application thereof. The chitosan drug-carrying system specifically includes a chitosan drug carrier and loaded gemcitabine and CPI-613. In the present invention, CPI-613 combined with gemcitabine significantly inhibits the proliferation of pancreatic cancer cells and the release of mitochondrial ATP, has a significant curative effect on pancreatic cancer, and can be applied to the prevention and treatment of pancreatic cancer. At the same time, gemcitabine combined with CPI-613 chitosan contains The drug system has a stronger inhibitory effect on the proliferation of pancreatic cancer cells than the free state. The invention provides a new drug dosage form and treatment approach for the treatment of pancreatic cancer.

Description

technical field [0001] The invention belongs to the technical field of preparation of tumor treatment materials, in particular to a chitosan drug-carrying system and its preparation method and application. Background technique [0002] Pancreatic cancer is a common malignant gastrointestinal tumor. The current standard drug for clinical treatment of pancreatic cancer is gemcitabine, although gemcitabine and gemcitabine-based combination therapy have played a certain role in prolonging the survival of patients and improving their survival. , but most patients develop drug resistance after receiving treatment for several weeks, leading to chemotherapy failure. On the one hand, 90% of pancreatic cancer tissue is surrounded by a large amount of connective tissue, the cancer tissue area is highly fibrotic, and the blood supply of cancer cells is insufficient, resulting in a low concentration of drugs reaching the local area of ​​pancreatic cancer tissue. Types and growth factors...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/52A61K47/36A61K31/7068A61K31/20A61P35/00
CPCA61K9/5036A61K31/7068A61K31/20A61P35/00A61K2300/00
Inventor 黄林旋石松庆凌世长郭东波张洋何佳鹏游柏浩缑泽明龚军松
Owner SOUTH CHINA INST OF COLLABORATIVE INNOVATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products